We are monitoring the impact of COVID-19 on Europe Precision Medicine Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1400
Share on
Share on

Europe Precision Medicine Market Research Report – Segmented By Technology, Application, By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Size, Share, Trends, Growth Opportunities Assessment, Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1400
Pages: 145

The size of the Europe Precision Medicine Market was valued at USD 13.6 Billion in 2020 and is projected to reach USD 22.81 Billion by 2025, at a CAGR of 10.9% during the forecast period.

Precision Medicine refers to the tailoring of medical treatment to the individual characteristics of each patient. This new approach enables doctors to better assess disease risk, and predict the optimal therapy.

The precision medicine market is growing in the UK and is one of the leaders in the field of precision medicine. The UK government has invested 210 million pounds in the development of precision medicine and genome sequencing. This will help to promote better diagnosis for rare diseases, and those who are suffering from cancer can get better access to personalized treatment programs. Increasing support from the government and non-government organizations is a major factor enhancing the growth rate of the market. 

France is following the UK in leading dominant shares of the market. The French government launched a new platform called Human MEDicine (Hu-PreciMED) which included around 45 companies from digital as well as medical companies. This project will connect the companies to improve the current therapeutic method. Increasing COVID-19 cases is also ascribed to bolster the growth of the market. 

The precision market size is growing in Spain. The Spanish government has developed new infrastructure for personalized medicine. Also, the rise in disposable income is escalating the growth rate of the market. Increasing incidences of chronic diseases are additionally propelling the demand of the market. Raising awareness through campaigns and digital advertisements is also greatly influencing the demand for the precision market in Spain. Growing geriatric population is enhancing the growth rate of the market. 

This research report has been segmented and sub-segmented into the following categories:

  • By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics and Others.
  • By Application: Oncology, CNS, Immunology, Respiratory and Others.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

By Application, the oncology segment holds the largest market share, followed by the CNS and immunology segments.

By Technology, the drug discovery market holds the largest share, followed by gene sequencing and companion diagnostics and big data analytics is expected to grow at the highest CAGR.

Key market participants in the Europe Precision Medicine Market are Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics, are the major players of North America Precision Medicine market.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Technology                

                                5.1.1 Introduction           

                                5.1.2 Big Data Analytics

                                5.1.3 Bioinformatics       

                                5.1.4 Gene Sequencing

                                5.1.5 Drug Discovery      

                                5.1.6 Companion Diagnostics     

                                5.1.7 Others      

                                5.1.8 Y-o-Y Growth Analysis, By Technology         

                                5.1.9 Market Attractiveness Analysis, By Technology       

                                5.1.10 Market Share Analysis, By Technology      

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Oncology 

                                5.2.3 CNS            

                                5.2.4 Immunology          

                                5.2.5 Respiratory             

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Application         

                                5.2.8 Market Attractiveness Analysis, By Application        

                                5.2.9 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Type

                                                6.1.3.4 By Application

                                                6.1.3.5 By Indication

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Type

                                                6.1.4.4 By Application

                                                6.1.4.5 By Indication

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Type

                                                6.1.5.4 By Application

                                                6.1.5.5 By Indication

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Pfizer                            

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Roche                           

                8.3 Covance                      

                8.4 Novartis                       

                8.5 Qiagen                         

                8.6 Biocrates Life Sciences                          

                8.7 Teva Pharmaceutical                              

                8.8 Nanostring Technologies                      

                8.9 Laboratory Corporation of America Holdings                

                8.10 Medtronic                

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Precision Medicine Market, By Region, From 2020 to 2025 (USD Billion)
  2. Europe Precision Medicine Market, By Technology, From 2020 to 2025 (USD Billion)
  3. Europe Big Data Analytics Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe Bioinformatics Market, By Region, From 2020 to 2025 (USD Billion)
  5. Europe Gene Sequencing Market, By Region, From 2020 to 2025 (USD Billion)
  6. Europe Drug Discovery Market, By Region, From 2020 to 2025 (USD Billion)
  7. Europe Companion Diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  8. Europe Other Precision Medicine Technologies Market, By Region, From 2020 to 2025 (USD Billion)
  9. Europe Precision Medicine Market, By Application, From 2020 to 2025 (USD Billion)
  10. Europe Oncology Precision Medicine Market, By Region, From 2020 to 2025 (USD Billion)
  11. Europe CNS Precision Medicine Market, By Region, From 2020 to 2025 (USD Billion)
  12. Europe Immunology Precision Medicine Market, By Region, From 2020 to 2025 (USD Billion)
  13. Europe Respiratory Precision Medicine Market, By Region, From 2020 to 2025 (USD Billion)
  14. Europe Other Precision Medicine Applications Market, By Region, From 2020 to 2025 (USD Billion)
  15. U.K Precision Medicine Market, By Technology, From 2020 to 2025 (USD Billion)
  16. U.K Precision Medicine Market, By Application, From 2020 to 2025 (USD Billion)
  17. Spain Precision Medicine Market, By Technology, From 2020 to 2025 (USD Billion)
  18. Spain Precision Medicine Market, By Application, From 2020 to 2025 (USD Billion)
  19. Germany Precision Medicine Market, By Technology, From 2020 to 2025 (USD Billion)
  20. Germany Precision Medicine Market, By Application, From 2020 to 2025 (USD Billion)
  21. Italy Precision Medicine Market, By Technology, From 2020 to 2025 (USD Billion)
  22. Italy Precision Medicine Market, By Application, From 2020 to 2025 (USD Billion)
  23. France Precision Medicine Market, By Technology, From 2020 to 2025 (USD Billion)
  24. France Precision Medicine Market, By Application, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample